Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil in ED secondary to spinal cord injury
NCT00654680Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2002
- Primary completion
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of vardenafil in erectile dysfunction (ED), sponsored by Bayer. Started Oct 2002; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00654680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654680.